HMOX1 and colorectal carcinoma: In an experiment with CRC xenograft model mice, cetuximab enhanced RSL3-induced ferroptosis by inhibiting the Nrf2/HO-1 axis to suppress the weight and volume of CRC tumor cells, which has potential positive significance for the treatment of CRC (Yang et al., 2021).